Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any brachydactyly type E in which the cause of the disease is a mutation in the HOXD13 gene.
Features include: Moderately short stature, Type E brachydactyly, Brachydactyly, and Multiple impacted teeth and 5 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 1 | Moderately short stature |
Head and neck |
HOXD13 encodes homeobox D13 (343 aa). Sequence-specific transcription factor that binds gene promoters and activates their transcription. Highest expression in Colon Sigmoid (34.0 TPM) and Vagina (31.9 TPM).
Brachydactyly type E1 is associated with mutations in the HOXD13 gene on chromosome 2.
HOXD13 is classified as a druggable target (Clinically Actionable and Transcription Factor categories) with score 26.1.
Genetic testing for HOXD13 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for brachydactyly type E1 has been reported in the published literature.
No clinical trials have been registered for brachydactyly type E1.
7 publications have been identified in PubMed for brachydactyly type E1. Research spans Basic Science / Preclinical (29%), Other (14%), and Diagnostic / Biomarker (14%).
Unknown (2026). [PMID: 41790440](https://pubmed.ncbi.nlm.nih.gov/41790440/). *J Bone Miner Res*. [Other]
Monahan G (2025). [PMID: 41031626](https://pubmed.ncbi.nlm.nih.gov/41031626/). *Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research*. [Basic Science / Preclinical]
Wang X (2025). [PMID: 40589517](https://pubmed.ncbi.nlm.nih.gov/40589517/). *Frontiers in endocrinology*. [Diagnostic / Biomarker]
Gallegos FR (2025). [PMID: 39803890](https://pubmed.ncbi.nlm.nih.gov/39803890/). *American journal of hypertension*. [Review / Meta-Analysis]
Ramakrishnan A (2024). [PMID: 39104441](https://pubmed.ncbi.nlm.nih.gov/39104441/). *JCEM case reports*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
Online Mendelian Inheritance in Man
1
Round face |
Luft FC (2024). [PMID: 39355912](https://pubmed.ncbi.nlm.nih.gov/39355912/). *Hypertension (Dallas, Tex. : 1979)*. [Gene Therapy / Novel Therapeutics]
Aydin A (2024). [PMID: 38331475](https://pubmed.ncbi.nlm.nih.gov/38331475/). *Life science alliance*. [Basic Science / Preclinical]